App-Based Tracking of Self-Reported COVID-19 Symptoms: Analysis of Questionnaire Data

by | Jun 29, 2020 | Research Publications

Author(s):

  • Martin Zens
  • Arne Brammertz
  • Juliane Herpich
  • Norbert Südkamp
  • Martin Hinterseer

Abstract:

Background: COVID-19 is an infectious disease characterized by various clinical presentations. Knowledge of possible symptoms and their distribution allows for the early identification of infected patients.

Objective: To determine the distribution pattern of COVID-19 symptoms as well as possible unreported symptoms, we created an app-based self-reporting tool.

Methods: The COVID-19 Symptom Tracker is an app-based daily self-reporting tool. Between April 8 and May 15, 2020, a total of 22,327 individuals installed this app on their mobile device. An initial questionnaire asked for demographic information (age, gender, postal code) and past medical history comprising relevant chronic diseases. The participants were reminded daily to report whether they were experiencing any symptoms and if they had been tested for SARS-CoV-2 infection. Participants who sought health care services were asked additional questions regarding diagnostics and treatment. Participation was open to all adults (≥18 years). The study was completely anonymous.

Results: In total, 11,829 (52.98%) participants completed the symptom questionnaire at least once. Of these, 291 (2.46%) participants stated that they had undergone an RT-PCR (reverse transcription-polymerase chain reaction) test for SARS-CoV-2; 65 (0.55%) reported a positive test result and 226 (1.91%) a negative one. The mean number of reported symptoms among untested participants was 0.81 (SD 1.85). Participants with a positive test result had, on average, 5.63 symptoms (SD 2.82). The most significant risk factors were diabetes (odds ratio [OR] 8.95, 95% CI 3.30-22.37) and chronic heart disease (OR 2.85, 95% CI 1.43-5.69). We identified chills, fever, loss of smell, nausea and vomiting, and shortness of breath as the top five strongest predictors for a COVID-19 infection. The odds ratio for loss of smell was 3.13 (95% CI 1.76-5.58). Nausea and vomiting (OR 2.84, 95% CI 1.61-5.00) had been reported as an uncommon symptom previously; however, our data suggest a significant predictive value.

Conclusions: Self-reported symptom tracking helps to identify novel symptoms of COVID-19 and to estimate the predictive value of certain symptoms. This aids in the development of reliable screening tools. Clinical screening with a high pretest probability allows for the rapid identification of infections and the cost-effective use of testing resources. Based on our results, we suggest that loss of smell and taste be considered cardinal symptoms; we also stress that diabetes is a risk factor for a highly symptomatic course of COVID-19 infection.

Documentation:

https://doi.org/10.2196/21956

References:
  1. COVID-19 Coronavirus Pandemic. Worldometer. 2020.   URL: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1? [accessed 2020-06-26]
  2. Zheng Y, Ma Y, Zhang J, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020 May 5;17(5):259-260 [FREE Full text] [CrossRef] [Medline]
  3. Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol 2020 Jun 9;16(6):308-310 [FREE Full text] [CrossRef] [Medline]
  4. martinzens / covid-19-st. GitHub. 2020.   URL: https://github.com/martinzens/covid-19-st [accessed 2020-08-26]
  5. Statistisches Bundesamt. German Federal Office of Statistics.   URL: https://www.destatis.de [accessed 2020-08-26]
  6. COVID-19 in Deutschland. Robert Kock Institute.   URL: https://www.rki.de/DE/Home/homepage_node.html [accessed 2020-08-26]
  7. Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond) 2020 Mar 05;20(2):124-127 [FREE Full text] [CrossRef] [Medline]
  8. Gane S, Kelly C, Hopkins C. Isolated Sudden Onset Anosmia in COVID-19 Infection. A Novel Syndrome? Rhin 2020 Jun 01;58(3):299-301. [CrossRef]
  9. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med 2020 May 4;35(5):1545-1549 [FREE Full text] [CrossRef] [Medline]
  10. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 Apr 30;382(18):1708-1720 [FREE Full text] [CrossRef] [Medline]
  11. Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med 2020 Jul 11;26(7):1037-1040 [FREE Full text] [CrossRef] [Medline]
  12. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 2020 Mar 31:e3319 [FREE Full text] [CrossRef] [Medline]
  13. Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab 2020 May 01;318(5):E736-E741 [FREE Full text] [CrossRef] [Medline]
  14. Rossman H, Keshet A, Shilo S, Gavrieli A, Bauman T, Cohen O, et al. A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys. Nat Med 2020 May;26(5):634-638 [FREE Full text] [CrossRef] [Medline]